Home › Medullary Carcinoma
Medullary Carcinoma clinical trials recruiting in the U.S.
5 studies for Medullary Carcinoma are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RecruitingPhase 1/2
Ages 18 to 99 · All sexes · Updated Oct 6, 2026 · NCT06814496Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07142005Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04216732Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
RecruitingPhase 1
Ages 18 to 100 · All sexes · Updated Sep 22, 2026 · NCT07006727Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT03892993From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.